NEW DELHI: As communicated by the Serum Institute of India, the current monthly production capacity of anti-Covid vaccine Covishield is 250-275 million doses, the government informed Lok Sabha on Friday.
Further, as communicated by Bharat Biotech International Limited, Hyderabad, the current monthly production capacity of Covaxin is 50-60 million doses, Minister of State for Health Bharati Pravin Pawar said in a written reply.
Responding to a question on whether the government has ascertained if the two approved COVID-19 vaccine manufacturers have achieved optimum production capacity, Pawar said, "Both companies have achieved close to 90 per cent of present production capacity."